Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.28 CAD | 0.00% |
|
+3.70% | -6.67% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 13.97 | 20.1 | 38.63 | 38.26 | 15.89 | 19.51 |
Enterprise Value (EV) 1 | 17.31 | 24.17 | 41.82 | 42.72 | 18.59 | 20.01 |
P/E ratio | -11.8 x | -18.8 x | 30.5 x | 24.1 x | -18 x | -18.5 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.35 x | 1.15 x | 2.23 x | 1.8 x | 0.56 x | 0.75 x |
EV / Revenue | 1.67 x | 1.39 x | 2.42 x | 2.01 x | 0.66 x | 0.76 x |
EV / EBITDA | -53.9 x | 61.5 x | 2,714 x | -75.7 x | -272 x | 20.1 x |
EV / FCF | -16.5 x | 36.5 x | 53.7 x | -24.1 x | 11.6 x | 10.3 x |
FCF Yield | -6.05% | 2.74% | 1.86% | -4.16% | 8.62% | 9.73% |
Price to Book | 2.07 x | 2.86 x | 3.93 x | 2.07 x | 0.85 x | 1.07 x |
Nbr of stocks (in thousands) | 59,640 | 61,464 | 65,612 | 79,295 | 86,209 | 86,209 |
Reference price 2 | 0.2343 | 0.3270 | 0.5888 | 0.4824 | 0.1844 | 0.2263 |
Announcement Date | 3/14/19 | 3/12/20 | 3/11/21 | 3/10/22 | 3/8/23 | 3/7/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 10.36 | 17.4 | 17.31 | 21.28 | 28.21 | 26.18 |
EBITDA 1 | -0.321 | 0.3927 | 0.0154 | -0.564 | -0.0683 | 0.9945 |
EBIT 1 | -0.7637 | -0.1128 | -0.3961 | -1.231 | -1.062 | 0.4602 |
Operating Margin | -7.37% | -0.65% | -2.29% | -5.79% | -3.77% | 1.76% |
Earnings before Tax (EBT) 1 | -1.041 | -0.9511 | 0.1255 | 2.473 | -1.207 | -1.366 |
Net income 1 | -0.9613 | -1.056 | 1.256 | 1.761 | -0.8357 | -1.055 |
Net margin | -9.28% | -6.07% | 7.26% | 8.27% | -2.96% | -4.03% |
EPS 2 | -0.0198 | -0.0173 | 0.0193 | 0.0200 | -0.0103 | -0.0122 |
Free Cash Flow 1 | -1.048 | 0.6625 | 0.778 | -1.776 | 1.602 | 1.946 |
FCF margin | -10.11% | 3.81% | 4.49% | -8.34% | 5.68% | 7.43% |
FCF Conversion (EBITDA) | - | 168.69% | 5,049.24% | - | - | 195.72% |
FCF Conversion (Net income) | - | - | 61.93% | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/14/19 | 3/12/20 | 3/11/21 | 3/10/22 | 3/8/23 | 3/7/24 |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 5.91 | 7.297 | 6.987 | 7.142 | 6.78 | 6.396 | 6.677 | 6.554 | 6.552 | 6.43 |
EBITDA 1 | -0.0589 | 0.2276 | 0.034 | 0.3255 | 0.0713 | 0.086 | 0.3861 | 0.4342 | 0.5713 | 0.3618 |
EBIT | - | - | - | - | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - |
Net income | - | - | - | - | - | - | - | - | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - |
EPS | - | - | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/10/22 | 5/12/22 | 8/12/22 | 11/10/22 | 3/8/23 | 5/11/23 | 8/10/23 | 11/9/23 | 3/7/24 | 5/9/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 3.34 | 4.08 | 3.18 | 4.47 | 2.69 | 0.5 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -10.4 x | 10.38 x | 206.5 x | -7.919 x | -39.44 x | 0.5065 x |
Free Cash Flow 1 | -1.05 | 0.66 | 0.78 | -1.78 | 1.6 | 1.95 |
ROE (net income / shareholders' equity) | -22.4% | -15.3% | 14.9% | 12.4% | -4.5% | -5.72% |
ROA (Net income/ Total Assets) | -6.21% | -0.53% | -1.56% | -3.47% | -2.62% | 1.28% |
Assets 1 | 15.48 | 198.9 | -80.32 | -50.68 | 31.93 | -82.23 |
Book Value Per Share 2 | 0.1100 | 0.1100 | 0.1500 | 0.2300 | 0.2200 | 0.2100 |
Cash Flow per Share 2 | 0.0200 | 0.0300 | 0.0400 | 0.0200 | 0.0100 | 0.0100 |
Capex 1 | 0.02 | 0.02 | 0.01 | - | 0.07 | 0.03 |
Capex / Sales | 0.19% | 0.09% | 0.04% | - | 0.25% | 0.11% |
Announcement Date | 3/14/19 | 3/12/20 | 3/11/21 | 3/10/22 | 3/8/23 | 3/7/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.67% | 17.73M | |
+3.19% | 3.21B | |
+30.21% | 2.16B | |
0.00% | 1.89B | |
+84.05% | 770M | |
-8.41% | 475M | |
-44.36% | 316M | |
-24.25% | 164M | |
-11.43% | 138M |
- Stock Market
- Equities
- NLH Stock
- Financials Nova Leap Health Corp.